Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Your research
Country: Norway,Poland,Hungary,United Kingdom,Denmark,France,Netherlands,Italy,Belgium,Sweden
nct
Update Il y a 5 ans
FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients
The purpose of this study is to provide treatment for patients who have chronic lymphocytic leukemia (CLL), and to compare the use of rituximab added to fludarabine+cyclophosphamide (FC) with FC alone, to determine if rituximab lengthens the time a patient remains free of leukemia symptoms.
Country
Australia
,
Belgium
,
Canada
,
Denmark
,
France
,
Hungary
,
Italy
,
Netherlands
,
New Zealand
,
Norway
,
Poland
,
Romania
,
Russian Federation
,
Spain
,
Sweden
,
United Kingdom
,
United States
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes
The purpose of this study is to determine whether pioglitazone, once daily (QD), can delay the time to death, heart attack, acute coronary syndrome, heart bypass surgery, stroke, leg bypass surgery or amputation in patients with type 2 diabetes.
Country
Austria
,
Belgium
,
Czech Republic
,
Denmark
,
Estonia
,
Finland
,
France
,
Germany
,
Hungary
,
Italy
,
Latvia
,
Lithuania
,
Netherlands
,
Norway
,
Poland
,
Slovakia
,
Sweden
,
Switzerland
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
nct
Update Il y a 5 ans
Nilotinib in Newly Diagnosed Adult Philadelphia Chromosome & /or BCR-ABL Positive Chronic Myeloid Leukaemia in Chronic Phase
This study will assess the efficacy and safety of nilotinib in adult patients with newly diagnosed Philadelphia chromosome positive/BCR-ABL positive chronic myeloid leukaemia in chronic phase. The aim of the study is to confirm the rates of complete molecular remission (CMR) of nilotinib in newly diagnosed CML chronic phase patients in a pan-European population using the EUTOS standardized laboratories.
Country
Austria
,
Belgium
,
Bulgaria
,
Croatia
,
Czech Republic
,
Denmark
,
Estonia
,
Finland
,
France
,
Germany
,
Greece
,
Hungary
,
Italy
,
Latvia
,
Lithuania
,
Netherlands
,
Norway
,
Poland
,
Portugal
,
Romania
,
Slovakia
,
Slovenia
,
Spain
,
Sweden
,
Switzerland
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
European Organisation for Research and Treatment of Cancer (EORTC) (Belgium)
Update Il y a 5 ans
Chimeric anti-CD20 monoclonal antibody (Mabthera) in remission induction and maintenance treatment of relapsed follicular non-Hodgkin's lymphoma (NHL): a phase III randomised clinical trial (Intergroup Collaborative Study)
Not provided at time of registration
Country
Australia
,
Belgium
,
Canada
,
Denmark
,
Egypt
,
France
,
Hungary
,
Italy
,
Netherlands
,
New Zealand
,
Norway
,
Poland
,
Slovakia
,
Slovenia
,
South Africa
,
Sweden
,
Switzerland
,
United Kingdom
,
organs
None
Specialty
None
Closed trial
More information
1